Hershey trust co trustee sells $5.36m in Hershey co stock

Hershey Trust Co Trustee (Milton Hershey School) sold 30,000 HSY shares for $5.36M at ~$175.0–$181.40/share across June 29–July 1, leaving it with 1,316,119 direct shares. Offsetting the insider sales, Moody’s affirmed an A1 rating with a stable outlook and expects 2026 EBITDA growth from pricing and cost actions, while S&P also kept an ’A’ rating with a stable outlook. Evercore upgraded HSY to Outperform, citing improving confection demand trends into H2 2026.

Analysis

The trust sale is more optics than signal; the real overhang is the size of the latent convertible Class B position, which means HSY can face episodic supply without a true change in fundamental ownership. At 30x-plus earnings, the stock is already paying for flawless execution, so the bar is not whether margin expands, but whether that expansion is durable enough to justify another turn of multiple.

Credit looks cleaner than equity here. Stable rating actions imply lenders believe the company can grow through pricing and cost work, but that usually helps bond spreads faster than it helps a premium multiple, especially when volume elasticity is still untested. The first-order winners from successful pricing are not just HSY but also peers with less domestic concentration; the first-order losers are retailers and private-label confectionery that absorb the shelf-price inflation.

The contrarian miss is that the market may be treating analyst upgrades as confirmation rather than lagging evidence. The next 1-2 quarters are the key catalyst window: if unit volumes stay firm while gross margin inflects, the stock can hold up; if pricing masks any demand erosion, the multiple can compress 2-4 turns before estimates fall. The supply-chain leadership transition is a more important variable than the insider sale because cocoa procurement, inventory discipline, and service levels drive whether margin gains are repeatable.

Key Decisions for Investors

• Fade strength in HSY rather than chase it: if the stock holds above $182-$185 for 1-3 weeks without an earnings/guidance beat, buy a 1-2 month 180/170 put spread or initiate a small tactical short; target a 5-8% pullback, stop above $188.
• Relative value: long MDLZ / short HSY for the next 1-3 months as a hedge against HSY's richer valuation and higher domestic execution risk; thesis fails if HSY delivers >100 bps gross margin upside and stable unit growth on the next print.
• Prefer HSY credit over HSY equity in the capital structure book: stable outlooks should tighten spreads before the equity rerates; add bonds on any equity-driven weakness, but exit if management cuts FY guidance or volumes roll over mid-single-digits.
• Watch for a better long entry only on a post-earnings pullback into the low-$170s with confirmed retailer scan stability; absent that, the risk/reward is asymmetric to the downside.